Viking Therapeutics Stock Price History
| VKTX Stock | USD 51.63 0.10 0.19% |
Below is the normalized historical share price chart for Viking Therapeutics extending back to April 29, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Viking Therapeutics stands at 51.63, as last reported on the 22nd of November, with the highest price reaching 54.28 and the lowest price hitting 50.53 during the day.
If you're considering investing in Viking Stock, it is important to understand the factors that can impact its price. Viking Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0477, which indicates the firm had a -0.0477% return per unit of risk over the last 3 months. Viking Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Viking Therapeutics' Variance of 25.77, risk adjusted performance of (0.03), and Coefficient Of Variation of (2,006) to confirm the risk estimate we provide.
At this time, Viking Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 763.1 M in 2024, whereas Common Stock Total Equity is likely to drop 582.51 in 2024. . At this time, Viking Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 5.29 in 2024, whereas Price Earnings Ratio is likely to drop (21.46) in 2024. Viking Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of April 2015 | 200 Day MA 62.0079 | 50 Day MA 64.4213 | Beta 0.994 |
Viking |
Sharpe Ratio = -0.0477
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VKTX |
Estimated Market Risk
| 5.19 actual daily | 46 54% of assets are more volatile |
Expected Return
| -0.25 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Viking Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Viking Therapeutics by adding Viking Therapeutics to a well-diversified portfolio.
Price Book 6.3002 | Book Value 8.179 | Enterprise Value 4.8 B | Enterprise Value Ebitda (71.64) | Shares Float 105.5 M |
Viking Therapeutics Stock Price History Chart
There are several ways to analyze Viking Stock price data. The simplest method is using a basic Viking candlestick price chart, which shows Viking Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | October 25, 2024 | 78.03 |
| Lowest Price | November 18, 2024 | 49.11 |
Viking Therapeutics November 22, 2024 Stock Price Synopsis
Various analyses of Viking Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Viking Stock. It can be used to describe the percentage change in the price of Viking Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Viking Stock.| Viking Therapeutics Price Action Indicator | (0.72) | |
| Viking Therapeutics Accumulation Distribution | 227,136 | |
| Viking Therapeutics Price Daily Balance Of Power | 0.03 | |
| Viking Therapeutics Price Rate Of Daily Change | 1.00 |
Viking Therapeutics November 22, 2024 Stock Price Analysis
Viking Stock Price History Data
The price series of Viking Therapeutics for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 has a statistical range of 28.92 with a coefficient of variation of 9.28. The daily prices for the period are distributed with arithmetic mean of 63.38. The median price for the last 90 days is 64.12.| Open | High | Low | Close | Volume | ||
| 11/21/2024 | 51.30 | 54.28 | 50.53 | 51.63 | 3,287,725 | |
| 11/20/2024 | 52.70 | 53.04 | 50.40 | 51.53 | 3,634,292 | |
| 11/19/2024 | 48.75 | 51.68 | 47.85 | 51.51 | 5,477,882 | |
| 11/18/2024 | 49.10 | 50.51 | 47.65 | 49.11 | 4,815,343 | |
| 11/15/2024 | 53.18 | 53.20 | 48.98 | 49.58 | 8,128,299 | |
| 11/14/2024 | 55.00 | 56.00 | 53.56 | 53.57 | 3,856,059 | |
| 11/13/2024 | 61.23 | 61.23 | 54.54 | 55.06 | 6,888,865 | |
| 11/12/2024 | 62.46 | 62.50 | 57.37 | 60.60 | 8,309,698 | |
| 11/11/2024 | 68.80 | 68.87 | 62.81 | 62.97 | 4,548,346 | |
| 11/08/2024 | 68.74 | 70.41 | 65.77 | 68.48 | 3,878,444 | |
| 11/07/2024 | 66.10 | 69.10 | 64.80 | 68.85 | 3,876,048 | |
| 11/06/2024 | 65.59 | 66.38 | 62.80 | 65.87 | 5,940,957 | |
| 11/05/2024 | 63.53 | 67.73 | 62.50 | 64.63 | 8,514,305 | |
| 11/04/2024 | 78.30 | 79.10 | 62.80 | 63.14 | 29,570,658 | |
| 11/01/2024 | 73.67 | 75.28 | 72.45 | 72.88 | 3,155,331 | |
| 10/31/2024 | 71.37 | 74.06 | 70.57 | 72.54 | 3,415,280 | |
| 10/30/2024 | 71.00 | 74.81 | 70.10 | 71.75 | 3,978,473 | |
| 10/29/2024 | 74.00 | 74.03 | 71.37 | 73.35 | 3,374,427 | |
| 10/28/2024 | 79.03 | 81.73 | 74.15 | 74.52 | 6,214,298 | |
| 10/25/2024 | 74.00 | 81.04 | 73.15 | 78.03 | 9,154,440 | |
| 10/24/2024 | 65.75 | 75.67 | 63.67 | 73.22 | 16,356,153 | |
| 10/23/2024 | 61.61 | 62.63 | 60.01 | 60.39 | 3,165,683 | |
| 10/22/2024 | 64.25 | 65.04 | 61.60 | 62.03 | 2,830,838 | |
| 10/21/2024 | 65.26 | 66.27 | 63.83 | 64.34 | 1,718,871 | |
| 10/18/2024 | 65.12 | 66.00 | 64.42 | 65.80 | 1,481,914 | |
| 10/17/2024 | 65.89 | 66.59 | 64.57 | 64.61 | 1,545,471 | |
| 10/16/2024 | 65.82 | 67.31 | 64.91 | 65.85 | 1,521,114 | |
| 10/15/2024 | 65.80 | 67.67 | 64.70 | 65.38 | 1,516,096 | |
| 10/14/2024 | 65.34 | 66.94 | 63.60 | 65.80 | 1,779,074 | |
| 10/11/2024 | 62.78 | 66.42 | 62.47 | 65.84 | 3,331,419 | |
| 10/10/2024 | 62.00 | 62.89 | 61.30 | 62.45 | 2,011,795 | |
| 10/09/2024 | 67.16 | 67.50 | 62.43 | 62.64 | 3,444,031 | |
| 10/08/2024 | 63.70 | 68.74 | 63.25 | 66.68 | 3,372,188 | |
| 10/07/2024 | 65.61 | 66.28 | 62.94 | 63.01 | 1,534,189 | |
| 10/04/2024 | 64.75 | 65.67 | 62.57 | 64.96 | 2,147,274 | |
| 10/03/2024 | 64.60 | 66.38 | 63.44 | 64.11 | 1,945,994 | |
| 10/02/2024 | 62.00 | 64.85 | 61.18 | 64.69 | 1,688,971 | |
| 10/01/2024 | 63.22 | 63.78 | 60.57 | 62.00 | 2,185,919 | |
| 09/30/2024 | 61.90 | 64.55 | 61.41 | 63.31 | 2,052,669 | |
| 09/27/2024 | 62.51 | 63.22 | 61.29 | 61.63 | 1,820,689 | |
| 09/26/2024 | 63.13 | 63.99 | 61.39 | 62.32 | 1,812,011 | |
| 09/25/2024 | 62.69 | 65.61 | 62.23 | 63.13 | 3,019,964 | |
| 09/24/2024 | 64.64 | 64.83 | 61.59 | 61.93 | 3,710,060 | |
| 09/23/2024 | 70.64 | 70.64 | 64.61 | 65.01 | 3,559,233 | |
| 09/20/2024 | 69.50 | 72.36 | 68.51 | 70.47 | 7,991,918 | |
| 09/19/2024 | 66.27 | 68.20 | 65.18 | 68.16 | 2,604,837 | |
| 09/18/2024 | 63.05 | 66.05 | 62.62 | 64.45 | 2,290,262 | |
| 09/17/2024 | 66.12 | 67.06 | 62.20 | 62.94 | 3,466,598 | |
| 09/16/2024 | 66.21 | 68.83 | 64.54 | 67.10 | 2,940,822 | |
| 09/13/2024 | 63.08 | 67.94 | 62.63 | 66.73 | 3,730,714 | |
| 09/12/2024 | 62.71 | 64.66 | 62.06 | 62.81 | 4,136,868 | |
| 09/11/2024 | 57.23 | 61.11 | 55.92 | 60.83 | 5,554,235 | |
| 09/10/2024 | 54.73 | 55.35 | 52.70 | 54.65 | 1,613,422 | |
| 09/09/2024 | 56.29 | 56.37 | 53.92 | 54.78 | 1,992,984 | |
| 09/06/2024 | 55.47 | 55.63 | 51.70 | 54.13 | 3,760,926 | |
| 09/05/2024 | 57.72 | 58.38 | 54.51 | 55.39 | 2,563,964 | |
| 09/04/2024 | 58.20 | 60.27 | 57.57 | 58.10 | 1,636,726 | |
| 09/03/2024 | 63.70 | 64.64 | 58.11 | 58.39 | 3,227,633 | |
| 08/30/2024 | 62.66 | 64.91 | 60.78 | 64.12 | 2,762,498 | |
| 08/29/2024 | 61.29 | 64.16 | 61.25 | 62.65 | 2,036,150 | |
| 08/28/2024 | 61.17 | 62.05 | 60.04 | 61.16 | 1,682,162 |
About Viking Therapeutics Stock history
Viking Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Viking is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Viking Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Viking Therapeutics stock prices may prove useful in developing a viable investing in Viking Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 94.3 M | 50.8 M | |
| Net Loss | -62 M | -58.9 M |
Viking Therapeutics Quarterly Net Working Capital |
|
Viking Therapeutics Stock Technical Analysis
Viking Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Viking Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Viking Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Viking Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Viking to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.39) | |||
| Total Risk Alpha | (0.84) | |||
| Treynor Ratio | (0.18) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Viking Stock Analysis
When running Viking Therapeutics' price analysis, check to measure Viking Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Therapeutics is operating at the current time. Most of Viking Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viking Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viking Therapeutics' price. Additionally, you may evaluate how the addition of Viking Therapeutics to your portfolios can decrease your overall portfolio volatility.